Familial melanoma: Clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family-Reference-Cited by-同舟云学术

Familial melanoma: Clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family

Published:2012-12 Issue:6 Volume:67 Page:1257-1264.e2
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Maubec Eve,Chaudru Valérie,Mohamdi Hamida,Blondel Christophe,Margaritte-Jeannin Patricia,Forget Sébastien,Corda Eve,Boitier Françoise,Dalle Stéphane,Vabres Pierre,Perrot Jean-Luc,Lyonnet Dominique Stoppa,Zattara Hélène,Mansard Sandrine,Grange Florent,Leccia Marie-Thérèse,Vincent-Fetita Lynda,Martin Ludovic,Crickx Béatrice,Joly Pascal,Thomas Luc,Bressac-de Paillerets Brigitte,Avril Marie-Françoise,Demenais Florence

Publisher

Elsevier BV

Subject

Dermatology

Reference34 articles.

1. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10;Ferlay,2010

2. Germline CDKN2A mutations in childhood melanoma;Whiteman;J Natl Cancer Inst,1997

3. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study;Berwick;Cancer Epidemiol Biomarkers Prev,2006

4. Selection criteria for genetic assessment of patients with familial melanoma;Leachman;J Am Acad Dermatol,2009

5. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL;Goldstein;Cancer Res,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐ and intermediate‐risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium;Journal of the European Academy of Dermatology and Venereology;2023-09-05

2. The management of hereditary melanoma, FAMMM syndrome and germline CDKN2A mutations: a narrative review;Australasian Journal of Plastic Surgery;2022-09-30

3. CDKN2A-positive melanoma patient treated with combination immunotherapy – A case report;Advances in Cancer Biology - Metastasis;2022-07

4. Clinical histopathological features and CDKN2A/CDK4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic;Italian Journal of Dermatology and Venereology;2021-11

5. CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations;Acta Oncologica;2021-05-04